Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 14, 2019
BioLineRx Reports First Quarter 2019 Financial Results and Provides Corporate Update
TEL AVIV, Israel, May 14, 2019 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for ...
May 14, 2019
InspireMD Announces First Quarter 2019 Financial Results
TEL AVIV, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
May 14, 2019
Lipocine Announces TLANDO™ NDA PDUFA Action Date of November 9, 2019
SALT LAKE CITY, May 14, 2019 /PRNewswire/ -- Lipocine Inc. (LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the ...
May 14, 2019
STRATA Skin Sciences Announces Preliminary First Quarter 2019 Financial Results and Updates
HORSHAM, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery ...
May 14, 2019
InflaRx Commences Second Phase II Clinical Trial of IFX-1 in ANCA-Associated Vasculitis with First Patient Treated in Europe
JENA, Germany, May 14, 2019 (GLOBE NEWSWIRE) -- InflaRx (IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced the ...
May 14, 2019
MediWound to Host First Quarter Financial Results Conference Call on May 21at 8:30 a.m. Eastern Time
YAVNE, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
May 14, 2019
Theravance Biopharma Announces Data from Phase 1b Study of TD-1473 to be Featured in Oral Presentation at Digestive Disease Week (DDW) 2019
DUBLIN, May 14, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced that results from the Company's Phase 1b study ...
May 14, 2019
Y-mAbs Announces Development Update on Cancer Vaccine Program
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (YMAB) a late-stage clinical biopharmaceutical company focused on the development ...
May 10, 2019
FDA Approves Prior Approval Supplement for BIVIGAM®
RAMSEY, N.J. and BOCA RATON, Fla., May 10, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
May 10, 2019
PolarityTE Reports First Calendar Quarter 2019 Results
SALT LAKE CITY, May 10, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today reported financial results ...
May 10, 2019
Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell ...
May 10, 2019
Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed ...
May 10, 2019
PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE
SALT LAKE CITY, May 10, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today data from ...
May 10, 2019
Immutep Announces Upcoming Industry Conference Participation
SYDNEY, Australia, May 10, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments ...
May 10, 2019
Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting
BERKELEY HEIGHTS, N.J., May 10, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
May 10, 2019
Quantum Genomics Announces the Publication of a New Scientific Article in the Journal Hypertension
PARIS and NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of ...
May 9, 2019
Chiasma Reports First Quarter 2019 Results
WALTHAM, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
May 9, 2019
Pfenex Reports First Quarter 2019 Results and Provides Business Update
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX) is a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex ...
May 9, 2019
Opiant Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
SANTA MONICA, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, ...
May 9, 2019
HTG Molecular Diagnostics Reports First Quarter 2019 Results
TUCSON, Ariz., May 09, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today ...
Page 16 of 158